3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Acute Coronary SyndromeCoronary Artery Disease
Interventions
DEVICE

Percutaneous coronary intervention

Percutaneous coronary intervention with scaffold implantation in patients with NSTE/ACS

Trial Locations (7)

1000

CHU Saint-Pierre, Brussels

1090

UZ Brussel, Brussels

3000

UZ Leuven, Leuven

11527

Hippocration Hospital, Athens

Unknown

UC Louvain, Leuven

Hippokration hospital, Thessaloniki

Geneva University Hospitals, Geneva

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire Saint Pierre

OTHER

collaborator

Université Catholique de Louvain

OTHER

collaborator

University Hospital of Leuven Leuven

OTHER

collaborator

University of Patras

OTHER

collaborator

Ippokrateio General Hospital of Thessaloniki

OTHER

lead

Konstantinos Toutouzas

OTHER

NCT06409117 - 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS | Biotech Hunter | Biotech Hunter